Silgan Holdings offers defensive, contract-protected cash flows and meaningful upside from Weener-led mix improvement, but 5.0x leverage and refinancing risk keep the opportunity execution-dependent.
Silgan Holdings Inc. is a leading global supplier of sustainable rigid packaging solutions, operating 120 manufacturing facilities across North and South America, Europe, and Asia [cite: 1, 2]. The company serves essential consumer goods markets, focusing on packaging for consumer staples that exhibit highly defensive demand characteristics even during periods of broader macroeconomic volatility [cite: 2, 3]. Silgan operates through three primary business segments: Dispensing and Specialty Closures, Metal Containers, and Custom Containers [cite: 2, 4]. Revenue is generated through the physical sale of packaging components directly to consumer packaged goods companies, with a significant structural safeguard provided by contractual mechanisms that pass through volatile raw material costs, such as steel, aluminum, and thermoplastic resins, directly to the end customer [cite: 5, 6, 7].
The core product suite is highly diversified and specialized across its operating units [cite: 2, 8]. The Dispensing and Specialty Closures segment manufactures highly engineered global fragrance dispensers, fine mist pumps, trigger sprayers, industrial valves, and specialized plastic and metal closures for food and beverage containers [cite: 2, 7]. The Metal Containers segment focuses on two-piece and three-piece steel and aluminum cans used primarily for human and pet food packaging [cite: 2, 7, 9]. The Custom Containers segment produces blow-molded custom plastic bottles and precision dosing systems tailored for shelf-stable food, household chemicals, and personal care products [cite: 2, 10, 11].
Geographically, Silgan's revenue is heavily weighted toward the United States, which accounts for approximately 50% of segment volumes, while Europe represents approximately 39%, and the Rest of the World contributes the remaining 11% [cite: 7]. The primary customer base consists of multinational consumer packaged goods companies, with a high concentration among market leaders [cite: 12, 13]. Nestlé S.A. and the Campbell Soup Company represent Silgan’s two largest customers, collectively accounting for 20.4% of total consolidated net sales in fiscal year 2025 [cite: 13].
CPG companies choose Silgan over alternative packaging suppliers due to its dominant scale, localized manufacturing footprint, and superior supply security [cite: 8, 14, 15]. Silgan is the largest manufacturer of metal food containers in North America, controlling more than half of the total market share by unit volume [cite: 14]. The packaging plants are often built adjacent to, or integrated directly with, customer filling facilities via conveyor systems, creating a localized geographic monopoly [cite: 7]. Furthermore, approximately 90% of North American metal container sales are secured under multi-year, long-term supply contracts, legally binding customers to Silgan and guaranteeing continuous supply reliability, localized engineering support, and co-developed product innovation [cite: 7, 14].
Silgan's primary revenue drivers are centered on volume stability within consumer staples, contractual raw material pass-throughs, and structural shifts toward higher-value dispensing systems [cite: 5, 16]. Net sales are heavily influenced by consumer staple replenishment cycles, agricultural harvest yields, and pet food demand [cite: 3, 5, 7]. The contractual pricing structures allow the company to protect its margins by passing raw material inflation directly to customers, meaning top-line revenue often expands during inflationary periods even if unit volumes remain flat [cite: 5, 6].
The company is executing several high-value organic and inorganic growth initiatives to drive long-term earnings power [cite: 15, 16]. The most significant strategic move is the expansion of its dispensing and specialty closures platform, accelerated by the October 2024 acquisition of Netherlands-based Weener Plastics for an enterprise value of €838 million (~$921.6 million net of cash acquired) [cite: 11, 17, 18]. This acquisition significantly enhances Silgan’s exposure to premium personal care, cosmetics, and healthcare packaging segments, which carry higher pricing power and stronger margins than traditional metal containers [cite: 16, 17]. Within healthcare, Silgan is leveraging its precision dosing and cleanroom manufacturing technologies to expand into ophthalmic and nasal drug delivery applications, representing a highly sticky, contract-backed, and high-margin product pipeline [cite: 5, 11, 19].
| Business Segment | Primary Product Details | Key Customers & End Markets | Strategic Revenue Drivers |
|---|---|---|---|
| Dispensing & Specialty Closures | Highly engineered global fragrance dispensers, fine mist pumps, trigger sprayers, metal vacuum closures, and child-resistant plastic caps [cite: 2, 7, 20] | Fragrance, beauty, personal care, healthcare, home care, and lawn and garden markets [cite: 2] | Premiumization in fine fragrance, drug delivery innovation, and Weener synergy capture [cite: 5, 16, 17] |
| Metal Containers | Two-piece and three-piece steel and aluminum food cans, composite closures, and easy-open ends [cite: 2, 9, 21] | Pet food manufacturers, canned soup, fruit and vegetable packers, and protein processors [cite: 7] | Secular wet pet food volume growth, agricultural harvests, and raw material pass-through [cite: 5, 6, 7] |
| Custom Containers | Custom-designed extrusion blow-molded plastic bottles, jars, precision dosing systems, and dual-chamber packaging [cite: 2, 10, 11] | Shelf-stable food, personal care, and household chemical brands [cite: 2] | Selective customer pruning, footprint optimization, and new commercial custom business wins [cite: 4, 16, 22] |
Silgan maintains a robust economic moat constructed around significant switching costs, cost advantages, scale, and proprietary intellectual property:
* High Customer Switching Costs: The physical integration of Silgan’s manufacturing plants with customer filling facilities creates high switching costs [cite: 7]. A customer seeking to replace Silgan would have to incur substantial capital expenditures to rebuild logistics pipelines, suffer severe production downtime, and break long-term contracts [cite: 7, 14]. In high-margin segments like healthcare drug delivery, switching packaging suppliers requires rigorous regulatory re-validation of the entire product line, making supplier relationships incredibly sticky [cite: 5].
* Contractual Cost Pass-Through Advantage: Silgan’s multi-year contracts cover 90% of North American metal container sales and a majority of dispensing and custom container sales [cite: 14, 23]. These contracts feature mathematical pass-through formulas for steel, aluminum, and thermoplastic resins [cite: 4, 7]. This shields the company from the raw material margin squeeze that typically harms standard manufacturing businesses, passing the inflation burden directly to CPG customers [cite: 5, 6].
* Scale and Geographic Density: Controlling more than 50% of the North American metal food container market creates a formidable cost barrier to entry [cite: 14]. New competitors cannot match Silgan's procurement leverage for steel and aluminum or its localized plant network, which minimizes transport costs for empty, highly bulky metal cans [cite: 7, 14].
* Proprietary Intellectual Property & Advanced Manufacturing: The company holds extensive patents on specialty closures, child-resistant mechanisms, and fine mist dispensing pumps [cite: 20]. The integration of Weener Plastics adds advanced cleanroom manufacturing capabilities and complex mold technologies, creating an entry barrier in medical and high-end beauty packaging [cite: 19, 24].
The global rigid packaging, caps, and closures markets present a massive and highly stable addressable opportunity [cite: 2, 20]. The global caps and closures market size is projected to reach $116.60 billion by 2033, driven by increasing consumer product safety requirements, child-resistant regulations, and the rising demand for convenient dispensing formats [cite: 20].
In Silgan's primary operating region, the North American metal caps and closures market is valued at $6.53 billion in 2025 and is projected to expand at a 3.81% compound annual growth rate to reach $7.87 billion by 2030 [cite: 25]. The pet food packaging market, which represents approximately 50% of Silgan’s metal container segment volume, continues to benefit from the secular humanization of pets and the transition toward premium wet food formats, which have historically grown at a mid-single-digit CAGR [cite: 7].
The packaging industry is moderately consolidated, with Silgan competing against large, well-capitalized global packaging players [cite: 20, 26]. In the metal containers space, the primary competitors are Crown Holdings, Sonoco Products, Ardagh Metal Packaging, and Trivium Packaging [cite: 12, 26]. In the dispensing and custom plastic container space, Silgan competes with AptarGroup and Berry Global [cite: 20, 27].
Silgan is favorably positioned relative to its peers. In the metal food can segment, it holds its ground as the dominant leader in North America, leveraging its localized footprint and long-term contracts to prevent market share erosion [cite: 7, 10, 14]. In the dispensing and specialty closures segment, Silgan is actively gaining ground [cite: 15]. The acquisition and integration of Weener Plastics have created a formidable global dispensing competitor, allowing Silgan to capture market share in Europe and the Americas through an accelerated product innovation pipeline and cross-selling agreements [cite: 15, 19].
In the custom plastic containers segment, Silgan is holding its ground while strategically pruning low-margin volume to focus on higher-margin, custom-designed applications, prioritizing profitability over pure volume market share [cite: 16, 22].
Silgan announced its most recent quarterly financial results for the second quarter of fiscal year 2026 on July 29, 2026 [cite: 1, 5]. The company’s operating metrics demonstrated resilience despite a mixed and dynamic global macroeconomic environment [cite: 4, 5].
During the second quarter of 2026, Silgan generated net sales of $1.643 billion, representing a 6.8% increase year-over-year compared to $1.539 billion in Q2 2025 [cite: 1, 16]. This top-line growth was primarily driven by the contractual pass-through of higher raw material and manufacturing costs to customers [cite: 5, 6]. Net income for the quarter stood at $75.8 million, or $0.72 per diluted share, down from $89.0 million, or $0.83 per diluted share, in the prior-year period [cite: 1, 28]. On an adjusted basis, diluted earnings per share (Adjusted EPS) came in at $0.98, compared to $1.01 in the second quarter of 2025 [cite: 1, 28].
Silgan’s second-quarter 2026 results were essentially in line with Wall Street expectations:
* Revenue Performance: Reported net sales of $1.643 billion missed the consensus analyst estimate of $1.653 billion by approximately $9.8 million, or a narrow 0.6% negative surprise [cite: 29].
* EPS Performance: Adjusted EPS of $0.98 narrowly trailed the consensus analyst expectation of $0.9813 by approximately 0.13% [cite: 3]. However, it came in above the midpoint of management's original expected guidance range and beat some conservative sell-side estimates pegged at $0.96 [cite: 5, 30, 31]. The fractional variance on both the top and bottom lines suggests that underlying operational execution remained highly stable [cite: 3].
Following the Q2 2026 earnings announcement, management reaffirmed its full-year fiscal 2026 Adjusted EPS guidance of $3.73 to $3.93, representing a 3% year-over-year increase at the midpoint compared to the $3.72 achieved in fiscal year 2025 [cite: 4, 22].
Management also confirmed its full-year 2026 free cash flow expectation of approximately $450 million [cite: 5, 22]. Capital expenditures are projected to be approximately $310 million, focused on expanding fragrance and pet food manufacturing capacity [cite: 5, 28]. For the third quarter of 2026, management issued Adjusted EPS guidance of $1.21 to $1.31, compared to $1.22 in Q3 2025 [cite: 5, 22].
On the Q2 2026 earnings call, CEO Adam Greenlee noted that Silgan successfully overcame mixed global operating conditions and severe volume headwinds in Brazil, which alone dragged down DSC segment volumes by 1% and negatively impacted product mix by 2% [cite: 5].
Management expressed confidence in sequential volume improvements in the second half of 2026, pointing to a recovery in Brazil starting in Q4, ongoing double-digit growth in global fine fragrance, the commercialization of new custom container business, and a new long-term supply agreement executed with a key vegetable pack customer [cite: 4, 5, 22].
The market’s reaction to the earnings release was positive but measured. The share price rose by 0.74% immediately following the announcement, reflecting investor relief that full-year guidance and cash flow targets remained completely intact [cite: 3]. Sell-side analysts maintained their broadly constructive stance.
Following the earnings release, several major research firms updated their target prices. Royal Bank of Canada (RBC) upgraded the stock and boosted its price target from $51.00 to $58.00 on August 13, 2026 [cite: 30, 32]. Raymond James reiterated an outperform rating with a $59.00 target [cite: 30, 31], while UBS Group maintained a neutral stance with a $47.00 price target [cite: 30, 31]. The average analyst consensus target price moved to $54.00, suggesting steady long-term appreciation [cite: 30, 31].
| Quantitative Metric | Q2 2026 Reported | Q2 2025 Reported | YoY Change (%) | Wall Street Consensus | Performance vs. Consensus |
|---|---|---|---|---|---|
| Net Sales | $1.643B [cite: 1] | $1.539B [cite: 1] | +6.8% [cite: 16] | $1.653B [cite: 29] | -0.6% (Miss) [cite: 29] |
| Adjusted EPS | $0.98 [cite: 1] | $1.01 [cite: 1] | -3.0% [cite: 1] | $0.9813 [cite: 3] | -0.13% (Met) [cite: 3] |
| GAAP Net Income | $75.8M [cite: 1] | $89.0M [cite: 1] | -14.8% [cite: 1] | N/A | N/A |
| Adjusted EBIT | $185.0M [cite: 5] | $193.0M [cite: 33] | -4.1% [cite: 5] | N/A | N/A |
| Free Cash Flow | N/A (Seasonal) | N/A (Seasonal) | N/A | N/A | N/A |
To properly evaluate Silgan, its valuation must be anchored directly to its stable cash flow business model rather than a simple assessment of trading multiples. Silgan trades at a forward P/E of approximately 14.6x, a material discount to the broader packaging peer group and the market average of over 26x [cite: 10].
This valuation discount is primarily driven by three core factors:
1. Modest Top-Line Organic Growth: Over the past five years, Silgan's organic sales CAGR has hovered around 2.4% [cite: 34]. Top-line growth has historically been driven by price adjustments and bolt-on acquisitions rather than rapid volume expansion [cite: 10, 34].
2. Elevated Balance Sheet Leverage: Following the debt-financed Weener acquisition, Silgan’s net debt reached approximately 5.0x EBITDA, compared to a broader market average of 1.26x [cite: 10]. This high debt load increases the cost of capital and consumes cash through substantial interest payments (~$200 million expected in 2026) [cite: 10, 22].
3. Capital-Intensive Model with FCF Squeeze: Sustaining Silgan's manufacturing footprint requires consistent capital expenditures, with a 10-year average segment CapEx of 3.7% of sales in metal containers [cite: 7]. While the business model generates highly dependable operating cash flow, heavy investment cycles and M&A integration costs can temporarily compress free cash flow yields [cite: 10].
The fundamental bull case relies on Silgan’s ability to transition its sales mix toward high-margin, highly proprietary dispensing and closures [cite: 16]. If Silgan can successfully capture Weener's projected €20 million in operational synergies, lower its leverage back to its historical target range of 2.5x to 3.5x, and expand its EBITDA margins through mix optimization, the stock is likely to undergo a fundamental re-rating [cite: 16, 19, 24].
| Annual Financial Metric | FY 2025 Actual | FY 2024 Actual | FY 2023 Actual | 5-Year CAGR / Growth Drivers |
|---|---|---|---|---|
| Net Sales | $6.48B [cite: 1] | $5.85B [cite: 10] | $5.99B [cite: 19] | 2.4% Sales CAGR [cite: 34], supported by Weener deal [cite: 10] |
| Adjusted EPS | $3.72 [cite: 1] | $2.59 [cite: 34] | $3.40 (Adjusted) | -2.0% EPS CAGR [cite: 34], impacted by unhedged leverage [cite: 16] |
| Net Income | $288.4M [cite: 1] | $276.5M | $326.0M | High interest expense and tax rate drag on net margins [cite: 16] |
| Free Cash Flow | $445.2M [cite: 1] | -$110.0M (Deals) | $342.8M [cite: 34] | Expected steady state at $450M annually from FY26 onward [cite: 5, 22] |
| Net Debt / EBITDA | ~5.0x [cite: 10] | ~3.2x | ~3.0x | Primary valuation drag; target deleveraging to 3.0x by FY29 [cite: 10, 24] |
Sustaining Silgan's long-term business viability requires a rigorous risk assessment of potential execution, competitive, and structural vulnerabilities.
The primary company-specific execution risk centers on senior leadership transition and acquisition integration [cite: 35]. Following a mutual agreement reached in September 2026, Chief Operating Officer Philippe Chevrier left his role [cite: 35, 36]. The departure of the COO introduces operational execution risk, as Chevrier was central to integrating the complex global footprint of Weener Plastics and capturing its €20 million operational synergy targets [cite: 17, 35]. Furthermore, the company previously acknowledged a material weakness in internal controls over financial reporting due to a lack of SEC financial reporting expertise, which increases compliance costs and the potential risk of reporting delays [cite: 37].
The rigid packaging industry is highly competitive, and peers could engage in aggressive pricing behaviors to defend volumes [cite: 9]. Competitors with massive scale in metal or plastic packaging, such as Crown Holdings, Ball Corporation, or Sonoco, could attempt to build localized capacity near Silgan’s un-contracted accounts [cite: 26, 38].
Silgan suffers from high customer concentration, with Nestlé S.A. and Campbell Soup Company collectively accounting for approximately 20.4% of total net sales [cite: 13]. CPG brands also face volatile end-consumer dynamics [cite: 22]. In late 2025, management highlighted a bifurcated North American consumer, with lower-income households purchasing fewer premium personal care products, leading to inventory adjustments and destocking among CPG brands [cite: 22, 39]. Furthermore, customer bankruptcies represent a recurring threat to the supply chain, as evidenced by a $10 million metal container volume loss tied to a customer bankruptcy in 2025 [cite: 33].
Silgan’s global footprint makes it sensitive to trade and environmental regulations [cite: 2, 15]. The metal container segment is highly exposed to steel and aluminum tariffs or quotas, particularly in Europe, which restrict supply and drive up procurement costs [cite: 15, 38]. Additionally, emerging ESG packaging laws, plastic recycling targets, and single-use plastic restrictions in the European Union could impact Weener’s injection molding operations [cite: 10, 19].
Silgan’s balance sheet is highly leveraged following consecutive debt-financed acquisitions [cite: 10]. Net debt currently stands at approximately 5.0x EBITDA, significantly higher than the broader market average [cite: 10]. This high debt burden requires significant annual interest expense (~$200 million), making Silgan sensitive to interest rate hikes [cite: 10, 22]. The company also faces a maturity wall, with significant outstanding debt scheduled for refinancing in mid-2026 [cite: 10].
The rigid packaging industry is capital-intensive, requiring constant capital reinvestment to maintain plant efficiency, tool molds, and meet customer-specific designs [cite: 7, 9]. High fixed-cost operating structures mean that small changes in capacity utilization can lead to oversized impacts on segment margins [cite: 16].
Silgan is sensitive to global inflation, consumer spending patterns, and energy costs [cite: 5, 22]. Higher crude oil prices directly inflate thermoplastic resin costs, compressing margins in the DSC and Custom Container segments before contractual pass-through pricing takes effect [cite: 22, 41]. Meanwhile, consumer wallet tightening could depress global fragrance and premium beauty demand [cite: 22, 39].
To project the long-term total return potential of Silgan Holdings Inc. over the next five years, three detailed operating scenarios have been constructed using a mathematical modeling approach. The current baseline share price is set at $41.50 with an annualized baseline dividend of $0.84 per share, reflecting the current quarterly payout of $0.21 [cite: 30, 42].
The modeled share price pathways over the 5-year projection horizon demonstrate the mathematical compounding of operating assumptions under each scenario [cite: 42].
| Scenario | Year 0 (Current) | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 (Exit) |
|---|---|---|---|---|---|---|
| High Case | $41.50 | $48.20 | $56.00 | $65.10 | $78.20 | $94.55 [cite: 42] |
| Base Case | $41.50 | $45.10 | $49.00 | $53.30 | $58.50 | $64.80 [cite: 42] |
| Low Case | $41.50 | $40.00 | $38.50 | $37.10 | $35.80 | $34.65 [cite: 42] |
By applying subjective probability weights to the projected Year 5 exit prices, the expected fundamental valuation target is calculated as follows:
$\text{Expected Price Target} = (0.55 \times \$64.80) + (0.25 \times \$94.55) + (0.20 \times \$34.65) = \$35.64 + \$23.64 + \$6.93 = \$66.21 \text{ USD [cite: 42]}$
This probability-weighted target of $66.21 USD represents a highly compelling long-term fundamental value proposition relative to the current share price of $41.50 [cite: 42].
| Scenario | Revenue / Key Scale Metric in Year 5 | Margin / Earnings Assumption | Valuation Multiple Assumption | Current Share Price | Implied Future Share Price | 5-Year Total Return | Annualized Return | Probability |
|---|---|---|---|---|---|---|---|---|
| High Case | 5.5% CAGR [cite: 42] | Adj. EPS of $6.10 [cite: 42] | 15.5x P/E [cite: 42] | $41.50 [cite: 42] | $94.55 USD [cite: 42] | 139.71% [cite: 42] | 19.11% [cite: 42] | 25% |
| Base Case | 3.2% CAGR [cite: 42] | Adj. EPS of $4.80 [cite: 42] | 13.5x P/E [cite: 42] | $41.50 [cite: 42] | $64.80 USD [cite: 42] | 67.33% [cite: 42] | 10.84% [cite: 42] | 55% |
| Low Case | 0.8% CAGR [cite: 42] | Adj. EPS of $3.15 [cite: 42] | 11.0x P/E [cite: 42] | $41.50 [cite: 42] | $34.65 USD [cite: 42] | -6.39% [cite: 42] | -1.31% [cite: 42] | 20% |
ASYMMETRIC RETURN DYNAMICS
| Scorecard Dimension | Numeric Rating (1-10) | Analytical Assessment |
|---|---|---|
| Management Alignment | 8 / 10 | High tenure, founder continuity, and performance-based equity incentive alignment [cite: 43]. |
| Revenue Quality | 8 / 10 | Protected by long-term contracts and direct cost pass-through agreements [cite: 7, 14]. |
| Market Position | 9 / 10 | Dominant market leader with >50% North American metal food container share [cite: 14]. |
| Growth Outlook | 6 / 10 | Stagnating legacy volumes offset by premium beauty and healthcare expansion [cite: 5, 22]. |
| Financial Health | 5 / 10 | High debt load (5.0x EBITDA) and upcoming mid-2026 debt refinancing timeline [cite: 10]. |
| Business Viability | 8 / 10 | Exceptionally durable model focused on essential consumer staple packaging [cite: 2, 3]. |
| Capital Allocation | 7 / 10 | Outstanding dividend track record offset by elevated acquisition leverage [cite: 1, 16]. |
| Analyst Sentiment | 8 / 10 | Highly constructive buy bias, with price targets recently upgraded to $57-$59 [cite: 30, 31]. |
| Profitability | 6 / 10 | Stable unit economics compressed by high interest expense and integration costs [cite: 16, 22]. |
| Track Record | 8 / 10 | Multi-decade history of defensive execution and successful M&A integration [cite: 10, 44]. |
| Blended Score | 7.3 / 10 | Balanced defensive equity with structural de-leveraging potential. |
BALANCED RISK-REWARD QUALITY
Silgan Holdings Inc. represents a highly resilient, defensive packaging company that is currently undervalued relative to its peer group and its long-term fundamental earnings power [cite: 10]. The core investment thesis is anchored in the company's transition away from slower-growing metal containers toward highly proprietary, high-margin dispensing and closures [cite: 16]. By expanding its exposure to premium fragrance, cosmetics, and medical drug delivery markets, Silgan is structurally enhancing its pricing power and operating margin profile [cite: 5, 16, 39].
The primary catalysts for a fundamental re-rating of the stock are:
* The successful integration of Weener Plastics and the full realization of its projected €20 million in operational synergies, which will expand margins in the Dispensing and Specialty Closures segment [cite: 17, 19].
* Sequential volume recovery in key international markets, particularly Brazil, and the commercialization of new custom plastic container programs [cite: 5, 22].
* Deleveraging the balance sheet from the current 5.0x EBITDA down toward the historical target range of 2.5x to 3.5x, which will reduce interest expense and free up cash flow for share repurchases [cite: 10, 24].
While elevated leverage and upcoming mid-2026 debt maturities represent near-term risks [cite: 10], Silgan's highly stable, contract-backed cash flows (~$450 million expected in FY26 free cash flow) provide a secure fundamental cushion [cite: 5, 22]. The market's current valuation of 14.6x forward earnings does not fully reflect the quality of the company's packaging moat, its automatic pricing pass-through protections, or its high-margin healthcare pipeline [cite: 7, 10]. For patient investors, Silgan offers defensive stability with significant upside as balance sheet risk is mitigated and the premium dispensing mix expands.
DEFENSIVE TRANSFORMATIONAL VALUE
Silgan’s stock is currently experiencing technical consolidation, with the share price resting near $41.50, slightly below its 50-day moving average of $43.71 but hovering near its rising 200-day moving average of $42.02 [cite: 31, 45]. The stock has faced technical resistance at the $43.00 level following its Q2 earnings print, yet it remains fundamentally supported by a highly secure 2.0% annualized dividend yield and strong institutional ownership of over 70% [cite: 30, 31, 32].
The short-term technical outlook is range-bound to slightly positive, with the stock likely to establish a solid support base near its 200-day moving average as the market digests the executive leadership transition and awaits confirmation of second-half volume acceleration and initial Weener integration synergies [cite: 5, 35].
SUPPORTED ON RECOVERY
View Silgan Holdings Inc. (SLGN) stock page
Loading the interactive version of this report…